Phase I/Ib Study of Azacitidine or Decitabine With Hedgehog Pathway Inhibition in Myeloid Malignancies
Phase of Trial: Phase I
Latest Information Update: 04 Nov 2019
Price : $35 *
At a glance
- Drugs Azacitidine (Primary) ; Azacitidine (Primary) ; Decitabine (Primary) ; Sonidegib (Primary)
- Indications Acute myeloid leukaemia; Chronic myelomonocytic leukaemia; Essential thrombocythaemia; Myelodysplastic syndromes; Myelofibrosis; Polycythaemia vera
- Focus Adverse reactions; Therapeutic Use
- 28 Oct 2019 Status changed from active, no longer recruiting to completed.
- 29 Aug 2019 Planned End Date changed from 1 Oct 2019 to 31 Dec 2020.
- 04 Apr 2019 Planned End Date changed from 1 Oct 2018 to 1 Oct 2019.